[1]
Aveek Datta et al. 2024. Design, Characterisation and Evaluation of Sustained Release Formulation of Remogliflozin Etabonate. Asian Journal of Pharmaceutical Research and Development. 12, 6 (Dec. 2024), 18–24. DOI:https://doi.org/10.22270/ajprd.v12i6.1431.